{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:42:40Z","timestamp":1792114960197,"version":"4.4.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.idc.2019.02.006","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T12:13:55Z","timestamp":1555503235000},"page":"545-566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients"],"prefix":"10.1016","volume":"33","author":[{"given":"Derek J.","family":"Bays","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"George R.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.idc.2019.02.006_bib1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A\u00a0controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.idc.2019.02.006_bib2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.idc.2019.02.006_bib3","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the transplant-associated infection surveillance network (TRANSNET) database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2019.02.006_bib4","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.idc.2019.02.006_bib5","first-page":"177","article-title":"Candida infections in bone marrow transplant recipients","volume":"8","author":"Verfaillie","year":"1991","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.idc.2019.02.006_bib6","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005792-199807000-00003","article-title":"The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis: an autopsy study of 355 patients","volume":"77","author":"Van Burik","year":"1998","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.idc.2019.02.006_bib7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2019.02.006_bib8","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of fks mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2019.02.006_bib9","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1128\/jcm.32.2.452-456.1994","article-title":"Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis","volume":"32","author":"Branchini","year":"1994","journal-title":"J\u00a0Clin Microbiol"},{"issue":"20","key":"10.1016\/j.idc.2019.02.006_bib10","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1002\/cncr.24507","article-title":"Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection","volume":"115","author":"Sipsas","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.idc.2019.02.006_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/TCRM.S40160","article-title":"Epidemiology and risk factors for invasive candidiasis","volume":"10","author":"Yapar","year":"2014","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"10.1016\/j.idc.2019.02.006_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.hemonc.2015.06.006","article-title":"Epidemiological and mycological characteristics of candidemia in patients with hematological malignancies attending a tertiary-care center in India","volume":"8","author":"Dewan","year":"2015","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"1","key":"10.1016\/j.idc.2019.02.006_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/13693786.2011.587211","article-title":"Epidemiology of Candida blood stream infections in patients with hematological malignancies or solid tumors","volume":"50","author":"Zirkel","year":"2012","journal-title":"Med Mycol"},{"issue":"11","key":"10.1016\/j.idc.2019.02.006_bib14","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/cncr.23466","article-title":"The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy","volume":"112","author":"Hachem","year":"2008","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.idc.2019.02.006_bib15","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1128\/JCM.01283-12","article-title":"Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011","volume":"50","author":"Lockhart","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2019.02.006_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0714.2010.00937.x","article-title":"Epidemiology of oral yeast colonization and infection in patients with hematological malignancies, head neck and solid tumors","volume":"40","author":"Schelenz","year":"2011","journal-title":"J\u00a0Oral Pathol Med"},{"issue":"2","key":"10.1016\/j.idc.2019.02.006_bib17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1079-2104(03)00296-8","article-title":"Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis","volume":"96","author":"Epstein","year":"2003","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"4","key":"10.1016\/j.idc.2019.02.006_bib18","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.tripleo.2009.11.026","article-title":"Oropharyngeal candidiasis in the era of antiretroviral therapy","volume":"109","author":"Thompson","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.idc.2019.02.006_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejim.2016.06.029","article-title":"Candidemia and invasive candidiasis in adults: a narrative review","volume":"34","author":"Antinori","year":"2016","journal-title":"Eur J Intern Med"},{"issue":"5","key":"10.1016\/j.idc.2019.02.006_bib20","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00134-017-4743-y","article-title":"The risk and clinical outcome of candidemia depending on underlying malignancy","volume":"43","author":"Lortholary","year":"2017","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.idc.2019.02.006_bib21","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/jac\/dkq053","article-title":"Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death","volume":"65","author":"Slavin","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.idc.2019.02.006_bib22","article-title":"Isavuconazole versus caspofungin in the treatment of candidemia and other invasive candida infections: the active trial","author":"Kullberg","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2019.02.006_bib23","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/bjo.2007.133405","article-title":"Ocular candidiasis: a review","volume":"92","author":"Shah","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.idc.2019.02.006_bib24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10096-008-0466-x","article-title":"Candida infective endocarditis","volume":"27","author":"Baddley","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2019.02.006_bib25","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/j.1439-0507.2012.02182.x","article-title":"New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis","volume":"55","author":"Rammaert","year":"2012","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.idc.2019.02.006_bib26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0891-5520(05)70128-8","article-title":"Hepatosplenic candidiasis. A manifestation of chronic disseminated candidiasis","volume":"14","author":"Kontoyiannis","year":"2000","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"10.1016\/j.idc.2019.02.006_bib27","doi-asserted-by":"crossref","first-page":"E185","DOI":"10.1111\/j.1469-0691.2012.03819.x","article-title":"Hepatosplenic candidiasis in the era of new antifungal drugs: a study in Paris 2000-2007","volume":"18","author":"De Castro","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"9577","key":"10.1016\/j.idc.2019.02.006_bib28","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0140-6736(07)60917-9","article-title":"Vulvovaginal candidosis","volume":"369","author":"Sobel","year":"2007","journal-title":"Lancet"},{"issue":"RR-15","key":"10.1016\/j.idc.2019.02.006_bib29","first-page":"1","article-title":"Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV medicine association\/Infectious Diseases Society of America","volume":"53","author":"Benson","year":"2004","journal-title":"MMWR Recomm Rep"},{"issue":"9","key":"10.1016\/j.idc.2019.02.006_bib30","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \u201cmissing 50%\u201d of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care","volume":"56","author":"Clancy","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2019.02.006_bib31","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1128\/JCM.00609-11","article-title":"Quantitation of Candida CFU in initial positive blood cultures","volume":"49","author":"Pfeiffer","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2019.02.006_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/JCM.00506-08","article-title":"Utility of galactomannan enzyme immunoassay and (1,3) beta-d-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients","volume":"47","author":"Hachem","year":"2009","journal-title":"J\u00a0Clin Microbiol"},{"issue":"12","key":"10.1016\/j.idc.2019.02.006_bib33","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1128\/JCM.43.12.5957-5962.2005","article-title":"Evaluation of a (1->3)-beta-d-glucan assay for diagnosis of invasive fungal infections","volume":"43","author":"Pickering","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"issue":"26","key":"10.1016\/j.idc.2019.02.006_bib34","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1056\/NEJMc053340","article-title":"1,3-beta-d-glucan in patients receiving intravenous amoxicillin-clavulanic acid","volume":"354","author":"Mennink-Kersten","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.idc.2019.02.006_bib35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1148\/radiology.166.2.3275982","article-title":"Hepatosplenic candidiasis: wheels within wheels","volume":"166","author":"Pastakia","year":"1988","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.idc.2019.02.006_bib36","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1148\/radiographics.14.5.7991822","article-title":"Ultrasound case of the day. Hepatosplenic candidiasis","volume":"14","author":"Lawrence","year":"1994","journal-title":"Radiographics"},{"issue":"2","key":"10.1016\/j.idc.2019.02.006_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/cld.491","article-title":"Hepatosplenic candidiasis","volume":"6","author":"Cornely","year":"2015","journal-title":"Clin Liver Dis"},{"issue":"12","key":"10.1016\/j.idc.2019.02.006_bib38","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/cid\/cis305","article-title":"Septic shock attributed to candida infection: importance of empiric therapy and source control","volume":"54","author":"Kollef","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2019.02.006_bib39","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/jac\/dks044","article-title":"Usefulness of corticosteroid therapy during chronic disseminated candidiasis: case reports and literature review","volume":"67","author":"Chaussade","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.idc.2019.02.006_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/jac\/dkp138","article-title":"In\u00a0vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species","volume":"64","author":"Thompson","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.idc.2019.02.006_bib41","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/JCM.42.10.4419-4431.2004","article-title":"Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus","volume":"42","author":"Pfaller","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"issue":"12","key":"10.1016\/j.idc.2019.02.006_bib42","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2019.02.006_bib43","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/cid\/civ507","article-title":"Aspergillus polymerase chain reaction: systematic review of evidence for clinical use in comparison with antigen testing","volume":"61","author":"White","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2019.02.006_bib44","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/jama.1985.03350360095027","article-title":"The management of pneumonias in immunocompromised patients","volume":"253","author":"Masur","year":"1985","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.idc.2019.02.006_bib45","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2019.02.006_bib46","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients","author":"Leeflang","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.idc.2019.02.006_bib47","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cid\/cir897","article-title":"Beta-glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3)","volume":"54","author":"Lamoth","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2019.02.006_bib48","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1128\/JCM.00637-14","article-title":"Rapid detection and identification of Mucormycetes in bronchoalveolar lavage samples from immunocompromised patients with pulmonary infiltrates by use of high-resolution melt analysis","volume":"52","author":"Lengerova","year":"2014","journal-title":"J\u00a0Clin Microbiol"},{"issue":"10","key":"10.1016\/j.idc.2019.02.006_bib49","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00746-18","article-title":"PCR-based approach targeting mucorales-specific gene family for diagnosis of mucormycosis","volume":"56","author":"Baldin","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"issue":"Suppl 3","key":"10.1016\/j.idc.2019.02.006_bib50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.idc.2019.02.006_bib51","first-page":"331","article-title":"Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009","volume":"60","author":"Campo","year":"2010","journal-title":"J\u00a0Infect"},{"issue":"4","key":"10.1016\/j.idc.2019.02.006_bib52","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/13693780802524506","article-title":"Epidemiology and outcome of scedosporium prolificans infection, a review of 162 cases","volume":"47","author":"Rodriguez-Tudela","year":"2009","journal-title":"Med Mycol"},{"issue":"1","key":"10.1016\/j.idc.2019.02.006_bib53","doi-asserted-by":"crossref","first-page":"e87784","DOI":"10.1371\/journal.pone.0087784","article-title":"Earlier diagnosis of invasive fusariosis with aspergillus serum galactomannan testing","volume":"9","author":"Nucci","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.idc.2019.02.006_bib54","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/432470","article-title":"Multicenter clinical evaluation of the (1-->3) beta-d-glucan assay as an aid to diagnosis of fungal infections in humans","volume":"41","author":"Ostrosky-Zeichner","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2019.02.006_bib55","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/13693780802454761","article-title":"Scedosporium prolificans: an emerging pathogen in France?","volume":"47","author":"Grenouillet","year":"2009","journal-title":"Med Mycol"},{"issue":"3","key":"10.1016\/j.idc.2019.02.006_bib56","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/13693780500474327","article-title":"Differences in beta-glucan levels in culture supernatants of a variety of fungi","volume":"44","author":"Odabasi","year":"2006","journal-title":"Med Mycol"},{"issue":"2","key":"10.1016\/j.idc.2019.02.006_bib57","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.ijid.2012.09.004","article-title":"Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: fungal infection database (FIND) analysis, 2005-2009","volume":"17","author":"Racil","year":"2013","journal-title":"Int J Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2019.02.006_bib58","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/AAC.00383-13","article-title":"Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP study)","volume":"57","author":"Alastruey-Izquierdo","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.idc.2019.02.006_bib59","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1128\/JCM.01582-14","article-title":"Cryptic and rare aspergillus species in Brazil: prevalence in clinical samples and in\u00a0vitro susceptibility to triazoles","volume":"52","author":"Negri","year":"2014","journal-title":"J\u00a0Clin Microbiol"},{"issue":"11","key":"10.1016\/j.idc.2019.02.006_bib60","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3324\/haematol.2011.044636","article-title":"Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009","volume":"96","author":"Nicolle","year":"2011","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.idc.2019.02.006_bib61","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/505870","article-title":"Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey","volume":"43","author":"Cornillet","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2019.02.006_bib62","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/thx.38.8.579","article-title":"What happens to patients with pulmonary aspergilloma? Analysis of 23 cases","volume":"38","author":"Rafferty","year":"1983","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.idc.2019.02.006_bib63","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/509917","article-title":"Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign","volume":"44","author":"Greene","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2019.02.006_bib64","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1378\/chest.106.4.1156","article-title":"Invasive pulmonary aspergillosis. MRI, CT, and plain radiographic findings and their contribution for early diagnosis","volume":"106","author":"Blum","year":"1994","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.idc.2019.02.006_bib65","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/cid\/civ154","article-title":"High resolution computed tomography angiography improves the radiographic diagnosis of invasive mold disease in patients with hematological malignancies","volume":"60","author":"Stanzani","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2019.02.006_bib66","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/jac\/dkv198","article-title":"Invasive mould sinusitis in patients with haematological malignancies: a 10 year single-centre study","volume":"70","author":"Davoudi","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.idc.2019.02.006_bib67","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1471-2334-11-250","article-title":"Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan","volume":"11","author":"Chen","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2019.02.006_bib68","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/MD.0b013e318274cd77","article-title":"Central nervous system aspergillosis: a series of 14 cases from a general hospital and review of 123 cases from the literature","volume":"91","author":"Kourkoumpetis","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"26","key":"10.1016\/j.idc.2019.02.006_bib69","doi-asserted-by":"crossref","first-page":"e1018","DOI":"10.1097\/MD.0000000000001018","article-title":"Cutaneous invasive aspergillosis: retrospective multicenter study of the French invasive-aspergillosis registry and literature review","volume":"94","author":"Bernardeschi","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/j.idc.2019.02.006_bib70","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1128\/JCM.36.11.3115-3121.1998","article-title":"Cutaneous aspergillosis","volume":"36","author":"van Burik","year":"1998","journal-title":"J\u00a0Clin Microbiol"},{"issue":"4","key":"10.1016\/j.idc.2019.02.006_bib71","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2019.02.006_bib72","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2141.2012.09156.x","article-title":"A\u00a0prospective, randomized study of empirical antifungal therapy for the treatment of chemotherapy-induced febrile neutropenia in children","volume":"158","author":"Caselli","year":"2012","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.idc.2019.02.006_bib73","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/cid\/cix130","article-title":"Changing epidemiology of invasive mold infections in patients receiving azole prophylaxis","volume":"64","author":"Lamoth","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2019.02.006_bib74","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin b for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"10020","key":"10.1016\/j.idc.2019.02.006_bib75","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by aspergillus and other filamentous fungi (secure): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.idc.2019.02.006_bib76","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/13693780500148350","article-title":"Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosis","volume":"44","author":"Clemons","year":"2006","journal-title":"Med Mycol"},{"issue":"1","key":"10.1016\/j.idc.2019.02.006_bib77","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1399-3062.2008.00349.x","article-title":"Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis: short communication","volume":"11","author":"Kontoyiannis","year":"2009","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2019.02.006_bib78","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1200\/JCO.2001.19.1.253","article-title":"Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia","volume":"19","author":"Caillot","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.idc.2019.02.006_bib79","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1439-0507.2010.02009.x","article-title":"Serum galactomannan strongly correlates with outcome of invasive aspergillosis in acute leukaemia patients","volume":"54","author":"Park","year":"2011","journal-title":"Mycoses"},{"issue":"8","key":"10.1016\/j.idc.2019.02.006_bib80","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2005-02-0733","article-title":"Improved outcome in central nervous system aspergillosis, using voriconazole treatment","volume":"106","author":"Schwartz","year":"2005","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.idc.2019.02.006_bib81","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) working group on zygomycosis between 2005 and 2007","volume":"17","author":"Skiada","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.idc.2019.02.006_bib82","first-page":"1629","article-title":"Mucormycosis in organ and stem cell transplant recipients","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2019.02.006_bib83","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients","volume":"34","author":"Marr","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2019.02.006_bib84","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0039-6257(05)80041-4","article-title":"Survival factors in rhino-orbital-cerebral mucormycosis","volume":"39","author":"Yohai","year":"1994","journal-title":"Surv Ophthalmol"},{"issue":"10","key":"10.1016\/j.idc.2019.02.006_bib85","first-page":"1068","article-title":"Mucormycosis in hematologic malignancies: an emerging fungal infection","volume":"85","author":"Nosari","year":"2000","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.idc.2019.02.006_bib86","first-page":"207","article-title":"Mucormycosis in hematologic patients","volume":"89","author":"Pagano","year":"2004","journal-title":"Haematologica"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2019.02.006_bib87","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2019.02.006_bib88","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.2214\/ajr.168.6.9168721","article-title":"Pulmonary mucormycosis: radiologic findings in 32 cases","volume":"168","author":"McAdams","year":"1997","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"10.1016\/j.idc.2019.02.006_bib89","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1086\/587991","article-title":"Reversed halo sign in invasive pulmonary fungal infections","volume":"46","author":"Wahba","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2019.02.006_bib90","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2019.02.006_bib91","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin b-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2019.02.006_bib92","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/589857","article-title":"Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"Reed","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2019.02.006_bib93","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1128\/AAC.01512-07","article-title":"In\u00a0vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species","volume":"52","author":"Guinea","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.idc.2019.02.006_bib94","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"VITAL and FungiScope Mucormycosis Investigators. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2019.02.006_bib95","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.idc.2006.06.002","article-title":"Emerging fungi","volume":"20","author":"Nucci","year":"2006","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"10.1016\/j.idc.2019.02.006_bib96","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00001432-200312000-00015","article-title":"Emerging moulds: Fusarium, Scedosporium and zygomycetes in transplant recipients","volume":"16","author":"Nucci","year":"2003","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2019.02.006_bib97","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/bmt.2015.263","article-title":"Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR Infection & Immune Reconstitution analysis","volume":"51","author":"Riches","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.idc.2019.02.006_bib98","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1086\/383319","article-title":"Fusarium infection in hematopoietic stem cell transplant recipients","volume":"38","author":"Nucci","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2019.02.006_bib99","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cncr.11510","article-title":"Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection","volume":"98","author":"Nucci","year":"2003","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.idc.2019.02.006_bib100","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1086\/509579","article-title":"Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006","volume":"43","author":"Lamaris","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2019.02.006_bib101","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJMra1216008","article-title":"Mold infections of the central nervous system","volume":"371","author":"McCarthy","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.idc.2019.02.006_bib102","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/CMR.00039-07","article-title":"Infections caused by Scedosporium spp","volume":"21","author":"Cortez","year":"2008","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 3","key":"10.1016\/j.idc.2019.02.006_bib103","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1469-0691.12465","article-title":"ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others","volume":"20","author":"Tortorano","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.idc.2019.02.006_bib104","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1128\/AAC.50.3.917-921.2006","article-title":"Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi","volume":"50","author":"Cuenca-Estrella","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2019.02.006_bib105","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1128\/AAC.01388-07","article-title":"Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients","volume":"52","author":"Troke","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.idc.2019.02.006_bib106","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/clinids\/4.6.1119","article-title":"Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience","volume":"4","author":"Meyers","year":"1982","journal-title":"Rev Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2019.02.006_bib107","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.bmt.1705149","article-title":"Occurrence of Pneumocystis jirovecii pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study","volume":"36","author":"De Castro","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.idc.2019.02.006_bib108","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10096-006-0149-4","article-title":"Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jirovecii pneumonia in cancer patients","volume":"25","author":"Torres","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2019.02.006_bib109","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1164\/ajrccm\/140.5.1204","article-title":". Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS.","volume":"140","author":"Limper","year":"1989","journal-title":"Am Rev Respir Dis"},{"issue":"24","key":"10.1016\/j.idc.2019.02.006_bib110","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.idc.2019.02.006_bib111","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1378\/chest.08-1309","article-title":"Polymerase chain reaction for diagnosing Pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates","volume":"135","author":"Azoulay","year":"2009","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.idc.2019.02.006_bib112","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1128\/JCM.05267-11","article-title":"Diagnostic accuracy of serum 1,3-beta-d-glucan for Pneumocystis jirovecii pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis","volume":"50","author":"Onishi","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"9","key":"10.1016\/j.idc.2019.02.006_bib113","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/jac\/dkw157","article-title":"ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Maertens","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.idc.2019.02.006_bib114","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/jac\/dkw158","article-title":"ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients","volume":"71","author":"Maschmeyer","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"Suppl 5","key":"10.1016\/j.idc.2019.02.006_bib115","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.1093\/cid\/ciu592","article-title":"Immunosuppression associated with novel chemotherapy agents and monoclonal antibodies","volume":"59","author":"Morrison","year":"2014","journal-title":"Clin Infect Dis"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552019300091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552019300091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:14:35Z","timestamp":1760195675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552019300091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":115,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0891552019300091"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2019.02.006","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2019.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}